# Next Vial reviews (2026): care, dosing and costs | This GLP The selector opens on the twelve-month card, and the month-to-month rate sits at the top of the same ladder. Publisher: This GLP Editorial Team Canonical: https://thisglp.com/reviews/next-vial Updated: 2026-10-28 By [This GLP Editorial Team](https://thisglp.com/about) · Updated September 2026 Year preselected, month on top # Next Vial review The selector opens on the twelve-month card, and the month-to-month rate sits at the top of the same ladder. ## The verdict Next Vial prices compounded semaglutide at $199 for a month billed monthly, while the selector a buyer lands on has already chosen the twelve-month card at $99 a month, paid as $1,188 at once. Both numbers sit side by side on the product page, so the cost of declining a year's commitment is visible before a single medical question is asked. **Disclosure:** This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. [How we make money](https://thisglp.com/disclosures). Category GLP-1 telehealth Molecule Semaglutide · Tirzepatide Form Injection States 49 From From $199/mo Dose published No Prescription Required Compounded Yes — not FDA-approved Pharmacy Named Availability 49 states Next Vial is a telehealth marketplace that sells compounded semaglutide and compounded tirzepatide as weekly injections, alongside a catalog that runs from hormone therapy and peptides to hair loss, cold sores and smoking cessation. Its footer describes the company as a platform connecting patients with independently licensed providers, and says it neither dispenses medication nor provides medical care itself. 1. ## Who writes the prescription, and what do they see? The FAQ names the clinician network plainly as MD Integrations, and it describes US-based physicians who review each questionnaire and reply within roughly a day of it being submitted. In certain states a video consultation or a live chat has to happen before a prescription is written. No individual physician is named anywhere on the site, and in most states the review rests on the written intake rather than a scheduled visit. A buyer chooses the medication and the plan length first, answers the medical questions second, and then uploads a photo with an ID, which the FAQ puts down to state rules on identifying patients. The card is billed when the medication ships, and the FAQ says a patient is contacted before each refill is charged, the ordinary courtesy that keeps an automatic renewal from arriving unannounced on a statement. 2. ## What happens when the dose goes up? Nothing on the product page prints a milligram beside any plan, so the dose a buyer starts on, and the doses that follow through the first four months of escalation, are left entirely to the provider. The page describes provider-personalized dosages at one all-in price without saying outright that a higher dose keeps the same figure. What the fifth month costs is a question to put to the provider before the first vial is opened. 3. ## What the price includes The semaglutide ladder runs from $199 billed monthly to $507 for three months, $894 for six and $1,188 for twelve, which work out to $169, $149 and $99 a month. Tirzepatide has its own ladder in the same selector once it is chosen, and no monthly membership fee is charged on either. A separate banner lower on the same page advertises plans at a monthly figure that matches no card in the selector above it. 4. ## What it claims, and what it cites Both lines are compounded, and the product page says so twice, adding that compounded medications are not FDA-approved and that the FDA has not verified their safety or effectiveness. The FAQ names the dispensing pharmacy as Manifest Pharmacy in Greer, South Carolina, with a phone number and weekday hours, which gives a buyer something concrete to check against a state pharmacy board before the first shipment arrives. ## Where it holds up, and where it does not - Strength: Clinician network named as MD Integrations - Strength: Dispensing pharmacy named with its address - Strength: Every rung printed with its upfront total - Strength: No monthly membership fee - Limitation: The default card is a twelve-month prepay - Limitation: No milligram dose printed beside any plan - Limitation: A banner figure matches no plan card - Limitation: No individual physician is named ## What the evidence says about this kind of treatment The assessment above is about Next Vial. These are about the drugs it sells, and they are traced to the primary literature. - [What happens to the dose, and to the side effects, over the first twenty weeks?](https://thisglp.com/research/how-long-does-nausea-last-on-a-glp1) - [How much of the weight lost is muscle, and what changes that?](https://thisglp.com/research/muscle-loss-on-glp1) - [What does the trial evidence show when treatment stops?](https://thisglp.com/research/stopping-glp1-and-weight-regain) Right for A buyer who wants to see the full cost of each commitment length, and the name of the pharmacy, before answering a single medical question. Wrong for A buyer who wants a milligram schedule, and what each month of it will cost, laid out before signing up. ## The evidence behind what Next Vial prescribes These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation. - [Cochrane Review of Semaglutide for Obesity: 18 Trials Graded](https://thisglp.com/research/semaglutide-cochrane-review) A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower. - [Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?](https://thisglp.com/research/tirzepatide-vs-semaglutide-which-works-better) In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points. ## How Next Vial compares | Seller | Who it suits | Go | | --- | --- | --- | | Belle Health | Someone who wants included nutrition and clinical support and can choose an appropriate supply commitment after discussing treatment. | | | Liberty | A reader who wants to know what kind of facility made the vial, and will accept a mid-market rate to get that in writing. | | | Science & Co | Patients who clarify the clinician, pharmacy and full plan terms before enrolling | | [Compare all providers side by side →](https://thisglp.com/best) More GLP-1 telehealth sellers reviews: [MultiMedRx](https://thisglp.com/reviews/multimedrx) [MyFastRx](https://thisglp.com/reviews/myfastrx) [MyStart Health](https://thisglp.com/reviews/mystart-health) [Näky](https://thisglp.com/reviews/naky) [NativeMed](https://thisglp.com/reviews/nativemed) [Navio MD](https://thisglp.com/reviews/navio-md) Sponsored alternative SkinnyRx Readers choosing tirzepatide, the one line with a published standing rate ## Frequently asked Is $99 a month what semaglutide costs? Only on the twelve-month plan, which is paid as $1,188 up front; the same selector prices a single month at $199, billed monthly, with no commitment beyond that month. Who writes the prescription? A physician from MD Integrations, the network that the Next Vial FAQ names, and in some states a video consultation or live chat has to take place before that prescription is written. Where does Next Vial ship? The FAQ lists forty-nine states by name, leaving Alaska off that list and making no mention of the District of Columbia, so a buyer in either place should ask before starting an intake. Is Next Vial legit? Next Vial is a GLP-1 telehealth sellers service. Its stated availability: 49 states. What our record does not establish: whether it bills insurance and how its intake works. Ask for those in writing before you pay. Is Next Vial expensive compared with other GLP-1 telehealth sellers? Next Vial publishes a starting figure of $199/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Next Vial above the median. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes. Or [compare every seller we cover](https://thisglp.com/best). **Research, not medical advice.** This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://thisglp.com/methodology) and [terms](https://thisglp.com/terms).